Skip to content

Loeb Guides Agile Therapeutics in Merger with Insud Pharma

Loeb & Loeb is featured in GlobeNewswire for representing Agile Therapeutics, a women’s health care company, in a definitive merger with Insud Pharma, a global pharmaceutical group.

The acquisition has an estimated value of $45 million and is expected to close in the third quarter of 2024.

For more information, please see GlobeNewswires’s website.